Clinical Trial Update: Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating autonomic function and cardiovascular risk in restless legs syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Snippet

Sponsor: Mauro Manconi | Conditions: Restless Legs Syndrome | Phase 4 | Status: COMPLETED